<DOC>
	<DOCNO>NCT00338507</DOCNO>
	<brief_summary>This clinical study design explore dose range identify method demonstrate efficacy Erdosteine patient stable Chronic Bronchitis associate Chronic Obstructive Pulmonary Disease .</brief_summary>
	<brief_title>Phase 2 Study - Erdosteine Patients With CB/COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<mesh_term>Erdosteine</mesh_term>
	<criteria>Adult patient clinical diagnosis stable CB associate COPD enter study . CB diagnose clinically patient document smoke history daily productive cough least 3 month per year least 2 consecutive year absence cause chronic cough . COPD define presence airflow obstruction spirometry asthma , bronchiectasis , cystic fibrosis ; active history lung cancer , respiratory failure , need longterm oxygen therapy ;</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Chronic Bronchitis</keyword>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
</DOC>